08.30.21
Catalent, Inc. it has reached an agreement to acquire Bettera Holdings, LLC, a manufacturer of gummy supplements, soft chews, and lozenges, for $1 billion, from private equity firm Highlander Partners, LP. The acquisition is expected to close before the end of 2021 and is subject to customary terms and closing conditions.
Bettera is expected to complement and accelerate the growth of Catalent’s global softgel and oral dose formulation and manufacturing business to provide consumer health brands with formulation expertise and high-quality, scalable manufacturing solutions.
Headquartered in Plano, TX, Bettera has approximately 500 employees and four production facilities in the U.S. (California, Indiana, New Jersey, and Virginia).
The acquisition will enable Catalent to expand its current consumer health technology platform with a wider range of technologies and ready-to-market product libraries, as well as a variety of packaging.
“This acquisition allows us to significantly accelerate the growth of our consumer health business and offer customers access to the substantial potential in gummies, soft chews, and lozenges, which are experiencing double-digit growth,” said Dr. Aris Gennadios, president, softgel and oral technologies, Catalent. “This acquisition is a key strategic move for Catalent’s Consumer Health business, where our leadership in manufacturing technologies and formulation can offer customers more product development opportunities and add manufacturing capacity in this dynamic and fast-growing segment.”
Bettera will complement and leverage Catalent’s network of consumer health manufacturing sites across North and South America, Europe, and Japan, offering formulation development, delivery and supply solutions to the global consumer health and beauty markets.
“Bettera was established with a vision to serve the needs of consumers who want to experience the benefits of nutritional supplements through more enjoyable and convenient dose forms,” said Jeff Hull, president and CEO of Highlander Partners. “Catalent has long had a similar vision, combined with specialized expertise, a history of successful innovation, a wide range of offerings, and the resources to help Bettera continue to grow and meet customer and consumer needs. Together, Catalent Consumer Health and Bettera are well positioned to continue Bettera’s mission of serving consumers and participating in the long-term growth of the self-care market.”
Bettera is expected to complement and accelerate the growth of Catalent’s global softgel and oral dose formulation and manufacturing business to provide consumer health brands with formulation expertise and high-quality, scalable manufacturing solutions.
Headquartered in Plano, TX, Bettera has approximately 500 employees and four production facilities in the U.S. (California, Indiana, New Jersey, and Virginia).
The acquisition will enable Catalent to expand its current consumer health technology platform with a wider range of technologies and ready-to-market product libraries, as well as a variety of packaging.
“This acquisition allows us to significantly accelerate the growth of our consumer health business and offer customers access to the substantial potential in gummies, soft chews, and lozenges, which are experiencing double-digit growth,” said Dr. Aris Gennadios, president, softgel and oral technologies, Catalent. “This acquisition is a key strategic move for Catalent’s Consumer Health business, where our leadership in manufacturing technologies and formulation can offer customers more product development opportunities and add manufacturing capacity in this dynamic and fast-growing segment.”
Bettera will complement and leverage Catalent’s network of consumer health manufacturing sites across North and South America, Europe, and Japan, offering formulation development, delivery and supply solutions to the global consumer health and beauty markets.
“Bettera was established with a vision to serve the needs of consumers who want to experience the benefits of nutritional supplements through more enjoyable and convenient dose forms,” said Jeff Hull, president and CEO of Highlander Partners. “Catalent has long had a similar vision, combined with specialized expertise, a history of successful innovation, a wide range of offerings, and the resources to help Bettera continue to grow and meet customer and consumer needs. Together, Catalent Consumer Health and Bettera are well positioned to continue Bettera’s mission of serving consumers and participating in the long-term growth of the self-care market.”
